Td Asset Management Inc Black Diamond Therapeutics, Inc. Transaction History
Td Asset Management Inc
- $106 Billion
- Q4 2024
A detailed history of Td Asset Management Inc transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 165,678 shares of BDTX stock, worth $400,940. This represents 0.0% of its overall portfolio holdings.
Number of Shares
165,678
Previous 219,678
24.58%
Holding current value
$400,940
Previous $955,000
62.93%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BDTX
# of Institutions
95Shares Held
47.6MCall Options Held
2.9KPut Options Held
82.4K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.5MShares$25.3 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.52MShares$20.6 Million0.36% of portfolio
-
Vestal Point Capital, LP New York, NY5.6MShares$13.6 Million0.71% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$10.8 Million0.68% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$7.79 Million0.0% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $87.9M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...